Market Capitalization (Millions $) |
2,297 |
Shares
Outstanding (Millions) |
58 |
Employees |
- |
Revenues (TTM) (Millions $) |
40 |
Net Income (TTM) (Millions $) |
-176 |
Cash Flow (TTM) (Millions $) |
91 |
Capital Exp. (TTM) (Millions $) |
24 |
Kymera Therapeutics Inc
Kymera Therapeutics Inc is a biotechnology company based in Cambridge, Massachusetts. It focuses on developing targeted protein degradation therapies to address various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. The company's proprietary platform enables the selective degradation of disease-causing proteins, providing a novel approach to drug development. By harnessing the body's natural protein degradation system, Kymera aims to create highly specific and effective treatments for previously challenging conditions.
Company Address: 200 Arsenal Yards Blvd Watertown 2472 MA
Company Phone Number: 285-5300 Stock Exchange / Ticker: NASDAQ KYMR
|